Cargando…
Selective miRNA Modulation Fails to Activate HIV Replication in In Vitro Latency Models
HIV remains incurable because of viral persistence in latent reservoirs that are inaccessible to antiretroviral therapy. A potential curative strategy is to reactivate viral gene expression in latently infected cells. However, no drug so far has proven to be successful in vivo in reducing the reserv...
Autores principales: | López-Huertas, María Rosa, Morín, Matías, Madrid-Elena, Nadia, Gutiérrez, Carolina, Jiménez-Tormo, Laura, Santoyo, Javier, Sanz-Rodríguez, Francisco, Moreno Pelayo, Miguel Ángel, Bermejo, Laura García, Moreno, Santiago |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614709/ https://www.ncbi.nlm.nih.gov/pubmed/31288207 http://dx.doi.org/10.1016/j.omtn.2019.06.006 |
Ejemplares similares
-
Selective miRNA inhibition in CD8(+) cytotoxic T lymphocytes enhances HIV-1 specific cytotoxic responses
por: Madrid-Elena, Nadia, et al.
Publicado: (2022) -
The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
por: López-Huertas, María Rosa, et al.
Publicado: (2017) -
Anti-latency agents to purge HIV reservoirs
por: Moreno, Santiago
Publicado: (2012) -
HCMV miRNA Targets Reveal Important Cellular Pathways for Viral Replication, Latency, and Reactivation
por: Diggins, Nicole L., et al.
Publicado: (2018) -
The switch between EBV latency and replication.
por: Miller, G.
Publicado: (1989)